The risk further increases if an underlying thrombophilia is present. Anticoagulants are drugs that treat blood clots, and help prevent blood clot formation in the veins and arteries. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have been studied and. Outside of pregnancy, oral anticoagulants are the mainstay of therapy for patients with mechanical heart valves. This is not the case when the pregnant women has a native valvulopathy in atrial fibrillation, a mechanical prosthesis or a coagulation anomaly. Many of the available anticoagulant agents may be used safely in pregnancy, but they are disadvantaged by competing efficacy and risks to the mother and fetus. Its worth noting that while evidencebased guideline recommendations for anticoagulation in pregnancy have been published, they are based primarily on observational studies and extrapolation of data from nonpregnant patients. A subset of pregnant patients requires anticoagulation during pregnancy andor in the postpartum period, including women at high risk of deep vein thrombosis and women with prosthetic heart valves, atrial fibrillation, cerebral venous sinus thrombosis, left ventricular dysfunction, and some women with fetal loss. Congestion within the pelvic veins from a gravid uterus leads to decreased blood flow to the lower extremities, and compression of the left iliac vein by the right iliac artery is a wellknown phenomenon. Pregnancy is associated with changes in haemostasis, including an increase in the majority of clotting factors, a decrease in the quantity of natural anticoagulants and a reduction in. Although warfarin is contraindi possible side effects and complications of therapy to cated during pregnancy, it is not contraindicated manage anticoagulants safely in pregnancy. Thrombophilias have been associated with both maternal and fetal. Pregnancy is characterized by physical and physiologic changes that contribute to a tendency to clot. The use of heparin and oral anticoagulants during pregnancy is problematic because these drugs have the potential to produce adverse effects in the mother and fetus.
Pharmacists letter includes 12 issues every year, with brief articles about new meds and hot topics. Anticoagulant therapy during pregnancy is indicated for the treatment and prophylaxis of venous thromboembolic disease and for the prevention and treatment of systemic embolism associated with valvular heart disease andor. Get concise advice on drug therapy, plus unlimited access to ce. Clinicians confront numerous practical issues in optimizing the use of anticoagulants to treat vte. May 10, 2019 we aimed to perform an analysis of individual case safety reports retrieved after the standardized meddra query pregnancy and neonatal topics for which directacting oral anticoagulants. Occasionally, anticoagulation is also indicated in pregnant women with valvular or congenital heart disease. Because of the risks to both mother and baby, this is a doubly challenging patient population for the delivery of safe, effective anticoagulation.
This guidance document addresses the use of doacs in women of childbearing potential, with particular focus on the preconceptual period, pregnancy and puerperium, and breast. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have. Women requiring anticoagulation need careful attention throughout pregnancy and the postpartum period. Get a printable copy pdf file of the complete article. Fetal and neonatal effects of anticoagulants used in. Some pregnant women require anticoagulation during pregnancy andor in. Thrombosis task force 1990 guidelines on oral anticoagulation. Anticoagulant therapy during pregnancy is indicated for the treatment and prophylaxis of venous thromboembolic disease and for the prevention and treatment. All major evidencebased guidelines recommend lmwh as the preferred anticoagulant for pregnant women. Warfarin continued throughout pregnancy offers the best thromboembolic protection. Anticoagulants acs are commonly used in pregnancy for prevention and management of thrombotic problems. Use of anticoagulants during pregnancy is challenging due to the potential teratogenic effects and dosing complexities of the various agents, and the management of anticoagulation around the time of labor. Anticoagulant therapy is complex and associated with substantial benefits and risks. These drugs are prescribed to patients to treat and prevent a variety of diseases and conditions dvt, pulmonary embolism, blood clot during atrial fibrillation.
Editorial management of anticoagulants during pregnancy. Current status of anticoagulation in pregnancy the risks associated with oral anticoagulants occur primarily during the second part of the. Novel oral anticoagulants have emerged from clinical development. Venous thromboembolic vte complications are a leading cause of maternal mortality in the developed world. Common side effects of these drugs are bruises, diarrhea, fever, intestinal gas, and headache.
Pregnancy is associated with a hypercoagulable state. Anticoagulants are medicines that keep your blood from clotting, or turning into solid clumps of cells that stick together. Association of anticoagulants in pregnancy 325 thrombotic complications with heparindependent igg antibody that induces thromboxane synthesis and platelet aggregation. Oral anticoagulants should not be prescribed in pregnancy except in the case of mechanical valves where this should be done in conjunction with consultant obstetrician, consultant haematologist, consultant cardiologist and with counselling and consent of the patient.
Several newer anticoagulants can be used in pregnancy table 3. The role of anticoagulants in the prevention of pregnancy. Current guidelines advocate 2 anticoagulation strategies. Unfractionated heparin, low molecular weight heparin, fondaparinux, and warfarin have been studied and employed extensively with direct thrombin inhibitors typically reserved for patients with complications or those requiring intervention. The respective indications for heparin and oral anticoagulants reflect their respective advantages and disadvantages for the.
The choice of anticoagulant therapy, the degree of monitoring, and the therapeutic target should be modulated by balancing the risks and the benefits to the mother and fetus. To reduce the incidence of vte in pregnancy, and improve outcomes, a wider understanding of the risk factors involved and a better identification of women at risk of thrombosis coupled with effective thromboprophylaxis and treatment of vte are required. We aimed to perform an analysis of individual case safety reports retrieved after the standardized meddra query pregnancy and neonatal topics for. Pdf anticoagulants in pregnancy leo brancazio academia.
These guidelines focus on the optimal management of anticoagulant drugs for the prevention and treatment of vte following the choice of an anticoagulant. Anticoagulation during pregnancy ash clinical news. The heparinoid danaparoid orgaran is an lmwh, a combination of heparan, dermatan, and chondroitin sulfate. Anticoagulation for pregnant women with acute deep vein thrombosis dvt or pulmonary embolism pe 5.
In a study of the transfer of warfarin into breast milk, less than 25 ng warfarin was detected per milliliter 102. Guidelines for use of anticoagulation in pregnancy. Pregnancy itself is a physiological procoagulant state and increases the risk of thrombosis. Oral anticoagulants vka and noac guidelines for prescribing. Unfortunately, as discussed above, the use of these agents during pregnancy carries a risk of teratogenicity and toxic fetal effects and increases the risk of pregnancy loss and maternal hemorrhage. The heparins are a group of anticoagulants that consist of unfractionated heparin, low molecular weight heparins, and heparinoids unfractionated heparin usually just called heparin needs to be given directly into the blood by intravenous iv injection, and inhibits thrombin and factor xa, factors necessary in the final stages of the blood clotting cascade. Anticoagulation in pregnant women with artificial heart valves.
Directacting oral anticoagulants doacs in pregnancy. Be able to describe the biochemical mechanisms of action, therapeutic uses, contraindications and adverse effects of the specific anticoagulant and fibrinolytic agents listed above. Apr 21, 20 anticoagulants remain the primary strategy for the prevention and treatment of thrombosis. Pdf anticoagulants in pregnancy andra james academia.
Although aspirin crosses the placenta, it is safe in low doses. Management of anticoagulants during pregnancy heart. Category c the existence of risks cannot be ruled out. Pregnancy planning in chronically anticoagulated women 4. In addition, women receiving chronic anticoagulation who are contemplating pregnancy need counseling regarding how to avoid the potential. In accordance with the northamerican guidelines american. May 17, 2016 pregnancy outcome was successful with no abnormalities detected on ultrasound scanning during pregnancy or in the infant. These risks may be further increased in the presence of an acquired or inherited thrombophilia. Although pregnancy induces a state of hypercoagulability, the thromoboembolic risks during a normal pregnancy are minor. Pregnancy is a hypercoagulable state that increases the risk of thromboembolic events. The choice of appropriate anticoagulant depends on the stage of pregnancy. Fda classification of drugs for use in pregnancy and breastfeeding fda classification according to risk in pregnancy category a no apparent risks.
Feb 01, 2009 prescribing anticoagulants to pregnant women can be difficult and stressful. Anticoagulants remain the primary strategy for the prevention and treatment of thrombosis. Prevention of dvtpe during pregnancy and postpartum. Theyre often called blood thinners, but these medications dont really thin your blood. However, the safety of higher doses of aspirin during the first pregnancy is uncertain. Multiple changes occur to the coagulation system as pregnancy progresses, with the largest changes being seen at term gestation. Get a printable copy pdf file of the complete article 925k, or click on a page image below to browse page by page. The choice of an anticoagulant requires consideration of maternal risks, potential for teratogenicity, the underlying condition necessitating the treatment, and cost.
Maternal and fetal concerns must be considered at all times, with a careful assessment of the risks and benefits of anticoagulant therapy in each patient. Our practices are largely consistent with guidelines from societies. May 03, 20 new anticoagulants such as direct factor xa inhibitors and direct thrombin inhibitors have been recently developed, but their experience in pregnancy is limited. Management of direct oral anticoagulants in women of. Physiological changes to coagulation during pregnancy pregnancy is associated with changes in haemostasis, including an increase in the majority of clotting factors, a decrease in the quantity of natural anticoagulants and a reduction in. Anticoagulants may be indicated during pregnancy for the treatment or prophylaxis of venous thromboembolism and, in patients with mechanical prosthetic cardiac valves, for the prevention of valve thrombosis and systemic embolisation. Safety of anticoagulants in pregnancy and breastfeeding. Fortunately, lowmolecularweight heparins lmwhs and unfractionated heparin are quite safe and efficacious when properly selected, dosed, and monitored. Anticoagulant, thrombolytic, and antiplatelet drugs.
Ginsberg and others published use of anticoagulants during pregnancy find, read and cite all the research you need on researchgate. For example, vitamin k antagonists are the most efficacious for preventing mechanical valve thrombosis, but they pose risks to the fetus. Choosing anticoagulant therapies during pregnancy involves a balance of risks and benefits to both the mother and fetus. Many of the available anticoagulant agents may be used safely. Use of anticoagulants during pregnancy and postpartum uptodate. Know the properties of agents that can reverse the actions of heparin and the oral anticoagulants. Jun 30, 2017 the use of anticoagulants and thrombolytics in pregnancy is an important consideration. Anticoagulants and antiplatelet drugs eliminate or reduce the risk of blood clots. Drugs used to treat anticoagulation during pregnancy the following list of medications are in some way related to, or used in the treatment of this condition.
334 160 1228 1442 340 206 274 1436 505 778 1086 611 1174 36 854 320 306 350 247 931 291 1543 1286 293 1139 88 701 1004 986 1008 258 14